To hear about similar clinical trials, please enter your email below
Trial Title:
Colonoscopy Check-up in People With Lynch Syndrome
NCT ID:
NCT06126120
Condition:
Lynch Syndrome
Conditions: Official terms:
Colorectal Neoplasms, Hereditary Nonpolyposis
Syndrome
Conditions: Keywords:
Lynch Syndrome
Colonoscopy
Surveillance
Study type:
Observational
Overall status:
Enrolling by invitation
Study design:
Time perspective:
Cross-Sectional
Summary:
Lynch Syndrome, an inherited condition, increases bowel cancer risk. People with Lynch
Syndrome are recommended to have regular colonoscopies where a camera in a tube is used
to look inside the bowel for cancer and for polyps (growths that sometimes can become
cancerous). UK guidelines recommend that people with Lynch Syndrome have colonoscopy
check-up every 2 years after reaching a certain age; however, they face many challenges
which make it difficult to have the recommended check-up.
Among a subset of people with Lynch Syndrome in England, this study will investigate the:
- percentage who are having colonoscopy check-up as recommended by UK guidelines
- factors influencing whether a person is more/less likely to have the recommended
colonoscopy check-up
- views, experiences, and challenges of living with Lynch Syndrome and colonoscopy
check-up
This study will collect information from people in the 'Lynch Syndrome registry pilot'
using a questionnaire. The Cancer Screening and Prevention Research Group (CSPRG) at
Imperial College London are conducting the Lynch Syndrome registry pilot, which is
recruiting people with Lynch Syndrome who are aged >18 years and in the Cancer Prevention
Programme 3 (CaPP3) trial, from Nov 2022-Nov 2023.
This study will include people in the Lynch Syndrome registry pilot who provided consent
on the registry pilot consent form to be contacted about future research and are aged ≥25
years. People who have had previous surgery to remove their rectum will be excluded.
The investigators will use the 'Views, experiences, and challenges of colonoscopy
check-up' questionnaire, together with a few pieces of additional information previously
collected as part of the Lynch Syndrome registry pilot.
Participation involves completing the questionnaire only. The study will take
approximately one year from administering the questionnaire to sharing results with
participants.
Criteria for eligibility:
Study pop:
This study will include people who are in the Lynch Syndrome registry pilot and meet the
eligibility criteria for the present study. The Lynch Syndrome registry pilot is
recruiting people with Lynch Syndrome who are aged >18 years and in the CaPP3 trial.
Sampling method:
Non-Probability Sample
Criteria:
Inclusion Criteria:
- People in the Lynch Syndrome registry pilot who have provided consent to be
contacted about future research and are aged ≥25 years
Exclusion Criteria:
- People who have had surgery involving removal of their rectum
Gender:
All
Minimum age:
25 Years
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
Cancer Screening and Prevention Research Group (CSPRG), Department of Surgery and Cancer, Queen Elizabeth The Queen Mother (QEQM) Building, St Mary's Hospital, Imperial College London
Address:
City:
London
Zip:
W2 1NY
Country:
United Kingdom
Start date:
January 17, 2024
Completion date:
December 2024
Lead sponsor:
Agency:
Imperial College London
Agency class:
Other
Source:
Imperial College London
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT06126120